154 related articles for article (PubMed ID: 35801334)
21. ACR Neck Imaging Reporting and Data Systems (NI-RADS): A White Paper of the ACR NI-RADS Committee.
Aiken AH; Rath TJ; Anzai Y; Branstetter BF; Hoang JK; Wiggins RH; Juliano AF; Glastonbury C; Phillips CD; Brown R; Hudgins PA
J Am Coll Radiol; 2018 Aug; 15(8):1097-1108. PubMed ID: 29983244
[TBL] [Abstract][Full Text] [Related]
22. Neck Imaging Reporting and Data System: More Than Just a Template.
Rhyner PA; Bhatt AA; Baugnon KL; Aiken AH
AJNR Am J Neuroradiol; 2022 Oct; 43(10):1400-1402. PubMed ID: 36574331
[TBL] [Abstract][Full Text] [Related]
23. NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.
Baugnon KL
Neuroimaging Clin N Am; 2022 Feb; 32(1):1-18. PubMed ID: 34809832
[TBL] [Abstract][Full Text] [Related]
24. Neck Imaging Reporting and Data System.
Aiken AH; Hudgins PA
Magn Reson Imaging Clin N Am; 2018 Feb; 26(1):51-62. PubMed ID: 29128006
[TBL] [Abstract][Full Text] [Related]
25. Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT.
Kim ES; Yoon DY; Moon JY; Baek S; Han YM; Seo YL; Yun EJ
Acta Radiol; 2019 Feb; 60(2):186-195. PubMed ID: 29754496
[TBL] [Abstract][Full Text] [Related]
26. Posttreatment Head and Neck Cancer Imaging: Anatomic Considerations Based on Cancer Subsites.
Hiyama T; Miyasaka Y; Kuno H; Sekiya K; Sakashita S; Shinozaki T; Kobayashi T
Radiographics; 2024 Mar; 44(3):e230099. PubMed ID: 38386602
[TBL] [Abstract][Full Text] [Related]
27. Negative Predictive Value of NI-RADS Category 2 in the First Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.
Wangaryattawanich P; Branstetter BF; Hughes M; Clump DA; Heron DE; Rath TJ
AJNR Am J Neuroradiol; 2018 Oct; 39(10):1884-1888. PubMed ID: 30166429
[TBL] [Abstract][Full Text] [Related]
28. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
29. Analysis of misses in imaging of head and neck pathology by attending neuroradiologists at a single tertiary academic medical centre.
Ferguson A; Assadsangabi R; Chang J; Raslan O; Bobinski M; Bewley A; Dublin A; Latchaw R; Ivanovic V
Clin Radiol; 2021 Oct; 76(10):786.e9-786.e13. PubMed ID: 34304864
[TBL] [Abstract][Full Text] [Related]
30. Cross-sectional imaging in cancers of the head and neck: how we review and report.
Tshering Vogel DW; Thoeny HC
Cancer Imaging; 2016 Aug; 16(1):20. PubMed ID: 27487932
[TBL] [Abstract][Full Text] [Related]
31. Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer.
Pai M; Park CH; Suh JH; Koh JH
Clin Nucl Med; 1999 Jul; 24(7):495-500. PubMed ID: 10402001
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
Chaiken L; Rege S; Hoh C; Choi Y; Jabour B; Juillard G; Hawkins R; Parker R
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):455-64. PubMed ID: 8407422
[TBL] [Abstract][Full Text] [Related]
33. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
Menda Y; Graham MM
Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
[TBL] [Abstract][Full Text] [Related]
34. Preliminary experience with thallous chloride T1 201-labeled single-photon emission computed tomography scanning in head and neck cancer.
Gregor RT; Valdés-Olmos R; Koops W; Balm AJ; Hilgers FJ; Hoefnagel CA
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):509-14. PubMed ID: 8615968
[TBL] [Abstract][Full Text] [Related]
35. The role of positron emission tomography with 18F-fluorodeoxyglucose in nodal staging of clinical and radiological N₀ head and neck cancers.
Cetin B; Atasever T; Akdemir UO; Senturk S; Tufan G; Turan N; Buyukberber S; Coskun U; Benekli M
Eur Arch Otorhinolaryngol; 2013 Aug; 270(8):2307-13. PubMed ID: 23283243
[TBL] [Abstract][Full Text] [Related]
36. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
37. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
38. The value of CT, MRI, and PET-CT in detecting retropharyngeal lymph node metastasis of head and neck squamous cell carcinoma.
Kim JH; Choi KY; Lee SH; Lee DJ; Park BJ; Yoon DY; Rho YS
BMC Med Imaging; 2020 Jul; 20(1):88. PubMed ID: 32727384
[TBL] [Abstract][Full Text] [Related]
39. [Clinical evaluation of 18-fluorine fluorodeoxyglucose positron emission tomography-CT imaging in head and neck tumors].
Li XP; Liang Y; Liu X; Wang QS; Wu HB
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):298-301. PubMed ID: 15338869
[TBL] [Abstract][Full Text] [Related]
40. The potential role of imaging techniques in avoiding neck dissection during salvage surgery after head and neck carcinoma treated with bioradiotherapy.
Rovira A; Tornero J; Taberna M; Oliva M; Montal R; Nogues J; Mari A; Viñals JM; Lozano A; Maños M; Mesia R
J Laryngol Otol; 2021 Nov; 135(11):970-975. PubMed ID: 34482849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
